Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
StockStory.org on MSN
1 profitable stock to own for decades and 2 facing challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...
Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
Researchers have built a new platform that produces ultrashort UV-C laser pulses and detects them at room temperature using ...
News-Medical.Net on MSN
CRISPR Cas12a3: A precise tool to halt viral protein production
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback